Lv63
1730 积分 2022-09-19 加入
ABS0650 ECONOMIC BURDEN AND LIFE QUALITY OF IgG4-RELATED DISEASE IN CHINA: A COMPARATIVE ANALYSIS OF THREE TREATMENT REGIMENS
7天前
已完结
Case 342: IgG4-related Hypertrophic Pachymeningitis
22天前
已完结
Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report
22天前
已完结
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis
22天前
已完结
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis: A Systematic Review
22天前
已完结
IgG4-related disease of the central and peripheral nervous systems
22天前
已完结
Obexelimab for the Treatment of IgG4-Related Disease
23天前
已关闭
Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study)
29天前
已完结
IgG4-related disease of the central and peripheral nervous systems
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers
1个月前
已完结
皖公网安备34019202002308
